Healthcare in spotlight for busy final week of June

SIGN UP FOR IPO BOUTIQUE’S FREE NEWSLETTER

There are ten IPOs on the schedule for this week including five healthcare offerings. Below is the IPO schedule for the upcoming week:

Tuesday – 6/27

Avenue Therapeutics (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain. Avenue Therapeutics originally planned to go public in early June but delayed due to market conditions. ‘ATXI’ amended its prospectus and has a new lead left underwriter on the offering, Oppenheimer & Co., and will now debut with decreased terms.

Esquire Financial Holdings (Nasdaq: ESQ) is a bank holding company headquartered in Jericho, New York and registered under the Bank Holding Company Act of 1956, as amended (the BHC Act)

Wednesday – 6/28

Mersana Therapeutics (Nasdaq: MRSN) is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.

Thursday – 6/29

Aileron Therapeutics (Nasdaq: ALRN) is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.

Blue Apron Holdings (NYSE: APRN) was founded in 2012 premised on a simple desire our founders wanted to cook at home with their families, but they found grocery shopping and menu planning burdensome, time consuming, and expensive.

Byline Bancorp (Nasdaq: BY) is a bank holding company headquartered in Chicago, Illinois and conduct all our business activities through our subsidiary, Byline Bank, a full service commercial bank.

Dova Pharmaceuticals, Inc. (Nasdaq: DOVA) is a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Investors of any size can indicate for the $DOVA offering through the selling group, Motif.

Tintri, Inc.’s  (Nasdaq: TNTR) mission is to provide large organizations and cloud service providers with an enterprise cloud platform that offers public cloud capabilities inside their own data centers and that can also connect to public cloud services.

Friday – 6/30

Akcea Therapeutics (Nasdaq: AKCA) is a late-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders.

Mota Group, Inc. (Nasdaq: MOTA) designs, manufactures and markets consumer products which includes recreational and commercial drones, smart wearables and innovative mobile accessories for smartphone and camera users. mortgage loans and other debt and debt-like commercial real estate investments. Investors of any size can indicate for the $MOTA offering through the selling group, Motif.

IPO BOUTIQUE for your Syndicate Needs!